Skip to main content
PharmSpace

Beta blockers · Cardiovascular

Metoprolol

metoprolol tartrate · metoprolol succinate · Lopresor® · Toprol-XL®(brand names vary by market)

The workhorse cardioselective beta blocker, in fast and slow clothing.

Illustration of Metoprolol as a tabletMET

Also: modified release, injection

Mechanism

Competitive antagonist at beta-1 adrenergic receptors: slows sinus rate, slows AV conduction, reduces contractility, and lowers renin release.

Open the interactive pathway

Indications

  • Hypertension
  • Angina
  • Rate control in atrial fibrillation
  • Heart failure with reduced ejection fraction (succinate)
  • Post myocardial infarction

Formulations

TabletModified releaseInjection

Dosing concepts

Formulation matters

Tartrate is immediate-release and dosed more than once daily; succinate is extended-release and dosed once daily. The heart-failure evidence is with succinate.

Heart failure

Start low and up-titrate slowly; beta blockade is introduced when the patient is euvolemic and stable, not during acute decompensation.

Concepts, not prescribing instructions. Practice numbers live in current references and local protocols.

Pharmacokinetics

Bioavailability
~50% (extensive first-pass)
Half-life
3-7 h (IR); extended by the succinate matrix
Elimination
hepatic: CYP2D6 substrate; poor metabolizers see higher exposure

Lipophilic, crosses the blood-brain barrier more than atenolol, which is why vivid dreams appear on its adverse-effect list.

Play with these concepts in the PK Lab

Adverse effects

  • Bradycardiacommon & serious
  • Fatiguecommon
  • Hypotension, dizzinesscommon
  • Bronchospasm in reactive airway diseaseseriousCardioselectivity is relative, not absolute, and fades at higher doses.
  • Masking of hypoglycemia symptomsseriousTremor and palpitations are blunted; sweating persists.
  • Vivid dreams, sleep disturbancecommon

Contraindications & precautions

Contraindications

  • Severe bradycardia or high-grade AV block without a pacemaker
  • Decompensated heart failure
  • Severe hypotension

Precautions

  • Asthma and COPD
  • Diabetes with hypoglycemia unawareness
  • Peripheral arterial disease
  • Abrupt discontinuation (rebound tachycardia and ischemia)

Interactions

Monitoring

Heart rate

The pharmacodynamic effect you titrate against · Baseline and at every dose change

Blood pressure

Hypotension limits titration

Symptoms: fatigue, exercise tolerance, orthostasis

Effectiveness and tolerability read at the bedside

Counselling points

  • Take it at the same time every day; extended-release tablets are swallowed whole, not crushed or chewed.
  • Do not stop it suddenly: the dose is tapered if it needs to come off.
  • You may feel more tired in the first weeks; this usually settles.
  • Check your pulse if you feel faint or unusually slow.

Clinical pearls

  • Same molecule, two drugs: tartrate and succinate are not interchangeable milligram for milligram in heart failure.
  • A resting heart rate in the 50s is acceptable if the patient feels well; treat the patient, not the number.

References & review

  • Metoprolol product monograph (consult the current version for your market) (monograph)
  • Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed. (reference-work)

Last reviewed 2026-08-15 · jurisdiction: global · drug information changes; verify against current references before practice use.